INTRODUCTION
============

The coexistence of multiple chronic conditions within an individual, also known as multimorbidity, is deemed the 'norm rather than the exception' in primary care and represents one of the most complex issues in modern medicine, yet it requires a more nuanced knowledge base and effective clinical practice.[@b1]^--^[@b6] Multimorbidity has been linked with many adverse health outcomes including more frequent and longer hospitalisations,[@b7]^--^[@b10] reduced functional status,[@b11]^--^[@b14] potentially harmful polypharmacy,[@b15]^--^[@b20] compromised patient safety,[@b9]^,^[@b13]^,^[@b21]^--^[@b22] reduced quality of life or increased treatment burden,[@b6]^,^[@b8]^,^[@b23]^--^[@b25] higher healthcare costs,[@b13]^,^[@b26]^--^[@b28] and higher mortality.[@b9]^,^[@b29]^--^[@b30] Creating a more informative profile of the accumulation of multiple chronic conditions over time is necessary and could provide much needed insight for a learning health system and a clinical approach that encourages both management and prevention.

More robust research that examines how multimorbidity develops over time and that uncovers the mechanisms through which these multiple chronic condition diagnoses accumulate will enhance the understanding of this increasing phenomenon.[@b1]^,^[@b6]^,^[@b26]^,^[@b31]^--^[@b33] This requires more than calculating the crude and adjusted prevalence estimates of multimorbidity, and rather, describing the longitudinal patterns and progression of increasingly complex clinical profiles. Because of difficulties in computation, research has tended to examine categories of co-occurring conditions or the most common pairs or triplets.[@b1]^,^[@b34]^--^[@b36] However, the conclusions that can be made from these studies are limited because the complexity of multimorbidity cannot be simplified into broad patterns or simple dyads and triads. Research is needed to determine all unique clusters that exist, in what sequence these multiple chronic conditions are diagnosed, and whether there are key predictors of this natural progression towards multimorbidity over time. This information can increase knowledge from somewhat redundant prevalence calculations, to articulating the dimensions of multimorbidity and then identifying individuals who would benefit from timely and tailored interventions for primary or secondary prevention.

The aim of this study was to determine the prevalence and characteristics of patients living with multimorbidity, as well as to describe the unique combinations (same chronic conditions without a specific sequence) and unique permutations (same chronic conditions with a specific sequence) of multimorbidity in primary care.

###### 

How this fits in

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  There is a need to examine how multimorbidity develops over time to create a more nuanced understanding of this phenomenon. This study found that the largest proportion of patients with multimorbidity were aged \<65 years, giving further support to the argument that multimorbidity is no longer just an issue for older patients and it must also be appropriately managed among younger patients. The study also found that the patterns of multimorbidity represented increasingly unique combinations and permutations, particularly as patient age and total number of chronic diseases increased, which builds from the international literature using a more in-depth analysis and describing a profile of multimorbidity using longitudinal clinical data. This research may lead to new approaches for improving the delivery of care for complex patients with multimorbidity, refocusing biomedical research on co-occurring chronic diseases, and informing more effective interventions for multimorbidity management and prevention.
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

METHOD
======

Study design and participants
-----------------------------

Data were derived from the Canadian Primary Care Sentinel Surveillance Network (CPCSSN) electronic medical record (EMR) database, which is a national database of longitudinal clinical data for primary care patients across Canada.[@b37]^--^[@b40] This study was a retrospective cohort analysis of the prospectively collected data from 1990 to 2013. The methodological protocol for this study has been published elsewhere.[@b41] Eligible patients were those receiving care from practices or providers who had consented to participating in the CPCSSN database. The representativeness of patient and provider characteristics has been compared with the broader Canadian population and it was identified that CPCSSN patients were slightly older than the age reported by the 2011 Canadian Census (mean age of CPCSSN patients was 3.5 years older), but followed the same patterns of sex distribution and residential location.[@b38] Adult patients were included in the analyses if they had at least one in-office encounter recorded in their EMR and if they were aged ≥18 years as of their first encounter date. Those patients who did not have a detectable in-office encounter recorded, who were under the age of 18 years at their first encounter date, or who opted out of contributing their data to the CPCSSN database, were excluded from analyses.

Identifying chronic conditions and multimorbidity
-------------------------------------------------

Diagnostic codes were recorded using the International Classification of Diseases, ninth revision (ICD-9) system, which was used to detect individual chronic condition diagnoses. To identify adult primary care patients with multimorbidity, a list of 20 chronic condition categories and corresponding ICD-9 codes were used. This was based on work conducted by a national research project called 'Patient-centred innovations for persons with multimorbidity',[@b42] which created a validated list based on previous multimorbidity literature and relevance to the primary care population.[@b43] These 20 chronic condition categories, and corresponding ICD-9 codes, have been published elsewhere.[@b41]^,^[@b43] The two common definitions of multimorbidity in the literature were used for this study: at least two and at least three chronic conditions.

Data collection and analysis
----------------------------

To form the CPCSSN database, EMR data are collected and de-identified from regional networks across eight Canadian provinces on a quarterly basis by data managers. Descriptive analyses were conducted using Stata software (version 14.1). The prevalence estimates and corresponding 95% confidence intervals (95% CI) were calculated using the total number of patients with at least two chronic conditions (MM2+) and the total number of patients with at least three chronic conditions (MM3+) as of the date of data extraction (30 September 2013). For both calculations, the denominator consisted of all adult patients in the final sample. To describe the characteristics of patients living with multimorbidity, mean and standard deviation (SD) were calculated for continuous variables, and distributions were explored among categorical variables.

To identify the number and type of unique combinations (unordered patterns) and unique permutations (ordered patterns) of multimorbidity, a computational analysis was conducted using a customised Java program called the Multimorbidity Cluster Analysis Tool.[@b44] An example of a combination is those patients diagnosed with the same three chronic conditions (for example, cancer, obesity, and hypertension), regardless of sequence. For example, some patients may have been diagnosed first with obesity, then hypertension, and later develop cancer. Other patients may have been diagnosed with obesity, then cancer, and then hypertension. Both sets of patients are clustered into the same combination. An example of a permutation is those patients diagnosed with the same three chronic conditions (for example, cancer, obesity, and hypertension), in the same sequence. That is, all patients who are diagnosed with cancer, then with obesity, and then with hypertension are clustered within the same permutation. In comparison, those patients diagnosed with obesity, then with cancer, and then with hypertension, are clustered within a different permutation. To identify the unique combinations, all diagnoses recorded in a patient's EMR, including those diagnosed on the same date, were included in the analysis. To identify the unique permutations, those chronic condition diagnoses recorded on the same date were removed.

RESULTS
=======

Prevalence and characteristics of multimorbidity
------------------------------------------------

A total of 367 743 adult primary care patients were included in the final sample ([Figure 1](#fig1){ref-type="fig"}). As seen in [Table 1](#table1){ref-type="table"}, there were 195 838 (53.3%) adult primary care patients living with MM2+ and 121 864 (33.1%) adult primary care patients living with MM3+. The sex- and age group-stratified prevalence rates of multimorbidity (MM2+ and MM3+) are shown in [Figure 2](#fig2){ref-type="fig"}. This prevalence was observed among those patients who were already seeking care from their primary care provider. For both definitions of multimorbidity, there was an increase in prevalence across the age groups (until the age group of ≥85 years) for female and male patients. The characteristics of all adult patients, as well as those with multimorbidity, are presented in [Table 1](#table1){ref-type="table"}. Patients living with MM2+ had a mean age of 59.0 years (SD = 17.0) and patients living with MM3+ had a mean age of 62.7 years (SD = 15.9). For both definitions, the largest proportion of patients were between the ages of 45 and 64 years (MM2+ = 40.6%; MM3+ = 39.6%) and 61.7% of patients with MM2+ were \<65 years.

![***Inclusion flowchart for final sample of adult primary care patients with at least one in-office encounter recorded during the data extraction period. CPCSSN = Canadian Primary Care Sentinel Surveillance Network. EMR = electronic medical record. ICD-9 = International Classification of Diseases, ninth revision.***](bjgpSep-2019-69-686-e647-OA-1){#fig1}

###### 

Characteristics of all adult primary care patients and those primary care patients with multimorbidity, defined as at least two chronic conditions (MM2+) or at least three chronic conditions (MM3+)

  **Patient-level variable**                       **All adult patients (*n* = 367 743)**            **Patients with MM2+ (*n* = 195 838)**   **Patients with MM3+ (*n* = 121 864)**
  ------------------------------------------------ ------------------------------------------------- ---------------------------------------- ----------------------------------------
  **Age in years**                                                                                                                            
    Mean (SD)                                      52.3 (18.3)                                       59.0 (17.0)                              62.7 (15.9)
    Range                                          18--114                                           18--114                                  18--114
                                                                                                                                              
  **Age category, years, *n* (%)**                                                                                                            
    18--34                                         74 539 (20.3)                                     17 466 (8.9)                             6119 (5.0)
    35--44                                         61 783 (16.8)                                     23 855 (12.2)                            10 719 (8.8)
    45--64                                         134 550 (36.6)                                    79 571 (40.6)                            48 254 (39.6)
    65--84                                         77 816 (21.2)                                     60 696 (31.0)                            45 961 (37.7)
    ≥85                                            19 055 (5.2)                                      14 250 (7.3)                             10 811 (8.9)
                                                                                                                                              
  **Sex, *n* (%)**                                                                                                                            
    Female                                         213 402[^a^](#tfn1){ref-type="table-fn"} (58.0)   113 209 (57.8)                           71 319 (58.5)
    Male                                           154 311[^a^](#tfn1){ref-type="table-fn"} (42.0)   82 629 (42.2)                            50 545 (41.5)
                                                                                                                                              
  **Residential location, *n* (%)**                                                                                                           
    Rural                                          59 740 (16.3)                                     32 607 (16.7)                            22 274 (18.3)
    Urban                                          207 192 (56.3)                                    102 151 (52.2)                           65 026 (53.4)
    Missing                                        100 811 (27.4)                                    61 080 (31.2)                            34 564 (28.4)
                                                                                                                                              
  **Median household income (Canadian dollars)**                                                                                              
    Median (IQR)                                   60 130 (12 497)                                   60 952 (12 497)                          61 175 (12 497)
    Range                                          22 457--181 454                                   22 457--181 454                          22 457--181 454
    Missing, *n* (%)                               100 811 (27.4)                                    61 263 (31.3)                            34 662 (28.4)
                                                                                                                                              
  **Total number of chronic conditions**                                                                                                      
    Mean (SD)                                      2.0 (1.8)                                         3.3 (1.5)                                4.2 (1.4)
    Range                                          0--14                                             2--14                                    3--14

There were missing data for sex for 30 patients (0.0%), but there was no missing data for sex for patients with MM2+ and patients with MM3+. IQR = Interquartile range.

![***Mean number of chronic conditions and prevalence estimates of multimorbidity among adult primary care patients, stratified by age group and by sex.***](bjgpSep-2019-69-686-e647-OA-2){#fig2}

Total number of combinations and permutations
---------------------------------------------

Following the computational analysis, the total number of unique combinations and unique permutations were calculated among each age group and for female and male patients ([Figure 3](#fig3){ref-type="fig"}). The total number of combinations in patients of all ages with MM2+ was 6075 for females and 4296 for males. After stratifying by age category, the largest number of unique combinations was detected among female and male patients aged 65--84 years, even though this was not the largest age group for patients with multimorbidity.

![***Total number of unique combinations and unique permutations among patients with MM2+, stratified by age group and by sex.***](bjgpSep-2019-69-686-e647-OA-3){#fig3}

The total number of permutations detected among female and male patients of all ages with multimorbidity was 14 891 and 9716, respectively. After stratifying by age category, the largest number of unique permutations was again detected among female and male patients aged 65--84 years. This indicates the complexity of those aged 65--84 years living with multimorbidity. Indeed, there were a large number of permutations that presented in a very low frequency of patients (13 858 permutations \[4981 combinations\] for less than five female patients and 8999 permutations \[3565 combinations\] for less than five male patients) (further information available from authors on request), signalling the distinct challenges of multimorbidity when specific patterns are considered.

Combinations and permutations of multimorbidity
-----------------------------------------------

The most frequent combinations and permutations, stratified by patient age, sex, and total number of chronic conditions, are presented in [Table 2](#table2){ref-type="table"} and [Table 3](#table3){ref-type="table"}. Among female patients of all ages with MM2+, the most common combination was anxiety or depression and obesity (*n* = 3991; 3.5%) and the most common permutation was anxiety or depression followed by obesity (*n* = 1160; 2.4%). In comparison, among male patients of all ages with MM2+, the most common combination was hypertension and obesity (*n =* 3866; 4.7%) and the most common permutation was musculoskeletal problem followed by obesity (*n* = 1051; 3.5%).

###### 

Most frequent unique combination clusters for patients with MM2+, stratified by total number of chronic diseases and by sex

  **Age group/Rank[^b^](#tfn3){ref-type="table-fn"}**   **At least two chronic conditions[^a^](#tfn2){ref-type="table-fn"}**   **At least three chronic conditions[^a^](#tfn2){ref-type="table-fn"}**                                                                                  
  ----------------------------------------------------- ---------------------------------------------------------------------- ------------------------------------------------------------------------ ----------- ------------ --------------------- ------------ ------------------ ------------
  **All ages, female: 113 209, male: 82 629**                                                                                                                                                                                                                                          
    1                                                   AD --- OB                                                              3991 (3.5)                                                               HT --- OB   3866 (4.7)   AD --- MP --- OB      1621 (1.4)   HL --- HT --- OB   1389 (1.7)
    2                                                   MP --- OB                                                              3837 (3.4)                                                               MP --- OB   3580 (4.3)   HT --- MP --- OB      1019 (0.9)   DB --- HT --- OB   1226 (1.5)
    3                                                   HT --- OB                                                              3491 (3.1)                                                               AD --- OB   2431 (2.9)   DB --- HT --- OB      869 (0.8)    HT --- MP --- OB   1061 (1.3)
                                                                                                                                                                                                                                                                                       
  **18--34 years; female: 11 507, male: 5959**                                                                                                                                                                                                                                         
    1                                                   AD --- OB                                                              1197 (10.4)                                                              AD --- OB   713 (12.0)   AD --- MP --- OB      373 (3.2)    AD --- MP --- OB   171 (2.9)
    2                                                   MP --- OB                                                              817 (7.1)                                                                MP --- OB   648 (10.9)   AD --- CA --- OB      205 (1.8)    CA --- MP --- OB   67 (1.1)
    3                                                   AD --- MP                                                              608 (5.3)                                                                AD --- MP   422 (7.1)    AD --- COPDA --- OB   131 (1.1)    AD --- CA --- OB   60 (1.0)
                                                                                                                                                                                                                                                                                       
  **35--44 years; female: 14 756, male: 9098**                                                                                                                                                                                                                                         
    1                                                   AD --- OB                                                              1140 (7.7)                                                               MP --- OB   932 (10.2)   AD --- MP --- OB      483 (3.3)    AD --- MP --- OB   241 (2.6)
    2                                                   MP --- OB                                                              1034 (7.0)                                                               AD --- OB   653 (7.2)    AD --- CA --- OB      234 (1.6)    HT --- MP --- OB   127 (1.4)
    3                                                   CA --- OB                                                              654 (4.4)                                                                HT --- OB   479 (5.3)    CA --- MP --- OB      170 (1.2)    CA --- MP --- OB   122 (1.3)
                                                                                                                                                                                                                                                                                       
  **45--64 years; female: 44 712, male: 34 856**                                                                                                                                                                                                                                       
    1                                                   MP --- OB                                                              1693 (3.8)                                                               HT --- OB   1999 (5.7)   AD --- MP --- OB      680 (1.5)    HL --- HT --- OB   785 (2.3)
    2                                                   HT --- OB                                                              472 (1.1)                                                                MP --- OB   1725 (4.9)   HT --- MP --- OB      551 (1.2)    HT --- MP --- OB   605 (1.7)
    3                                                   AD --- OB                                                              404 (0.9.)                                                               HL --- OB   1310 (3.8)   CA --- MP --- OB      426 (1.0)    DB --- HT --- OB   559 (1.6)
                                                                                                                                                                                                                                                                                       
  **65--84 years; female: 33 264, male: 27 430**                                                                                                                                                                                                                                       
    1                                                   HT --- OB                                                              1181 (3.6)                                                               HT --- OB   1092 (4.0)   DB --- HT --- OB      427 (1.3)    DB --- HT --- OB   536 (2.0)
    2                                                   DB --- OB                                                              146 (0.4)                                                                DB --- OB   678 (2.5)    HL --- HT --- OB      386 (1.2)    HL --- HT --- OB   468 (1.7)
    3                                                   CA --- OB                                                              343 (1.0)                                                                CA --- OB   377 (1.4)    HT --- MP --- OB      292 (0.9)    CA --- HT --- OB   262 (1.0)
                                                                                                                                                                                                                                                                                       
  **≥85 years; female: 8970, male: 5279**                                                                                                                                                                                                                                              
    1                                                   HT --- OB                                                              212 (2.4)                                                                CA --- HT   42 (0.8)     DB --- HT --- OB      59 (0.7)     DB --- HT --- OB   53 (1.0)
    2                                                   DE --- HT                                                              151 (1.7)                                                                HT --- OB   41 (0.8)     HT --- OB --- ORA     54 (0.6)     CD --- HT --- OB   38 (0.7)
    3                                                   CD --- HT                                                              126 (1.4)                                                                CD --- HT   36 (0.7)     CA --- HT --- OB      53 (0.6)     CA --- HT --- OB   29 (0.5)

Including data points where the time elapsing between chronic condition diagnoses was 0 days.

Rank indicates that the combinations are listed in order of frequency (starting with most frequent).

Combinations presented in alphabetical order.

Proportion of age group. AD = Anxiety or Depression. CA = Cancer. CD = Cardiovascular Disease. COPDA = Chronic Obstructive Pulmonary Disease or Asthma. DB = Diabetes. DE = Dementia. HL = Hyperlipidemia. HT = Hypertension. MP = Musculoskeletal Problem. OB = Obesity. ORA = Osteoarthritis or Rheumatoid Arthritis. The hyphens between conditions are used to identify combinations (unordered patterns).

###### 

Most frequent unique permutation clusters for patients with MM2+, stratified by total number of chronic conditions and by sex

  **Age group/Rank[^b^](#tfn7){ref-type="table-fn"}**   **At least two chronic conditions[^a^](#tfn6){ref-type="table-fn"}**   **At least three chronic conditions[^a^](#tfn6){ref-type="table-fn"}**                                                                      
  ----------------------------------------------------- ---------------------------------------------------------------------- ------------------------------------------------------------------------ --------- ------------- --------------- ----------- -------------- -----------
  **All ages; female: 47 381, male: 30 478**                                                                                                                                                                                                                               
    1                                                   AD ➔ OB                                                                1160 (2.4)                                                               MP ➔ OB   1051 (3.5)    AD ➔ OB ➔ MP    177 (0.4)   HT ➔ OB ➔ HL   675 (2.2)
    2                                                   MP ➔ OB                                                                1094 (2.3)                                                               HT ➔ OB   1179 (3.9)    MP ➔ OB ➔ AD    176 (0.4)   HT ➔ OB ➔ MP   374 (1.2)
    3                                                   AD ➔ MP                                                                909 (1.9)                                                                AD ➔ OB   1132 (3..8)   AD ➔ MP ➔ OB    161 (0.3)   DB ➔ OB ➔ HT   365 (1.2)
                                                                                                                                                                                                                                                                           
  **18--34 years; female: 5565, male: 2624**                                                                                                                                                                                                                               
    1                                                   AD ➔ OB                                                                388 (7.0)                                                                MP ➔ OB   443 (16.9)    MP ➔ OB ➔ AD    41 (0.7)    AD ➔ OB ➔ MP   157 (6.0)
    2                                                   AD ➔ MP                                                                249 (4.5)                                                                AD ➔ OB   397 (15.1)    AD ➔ OB ➔ MP    41 (0.7)    AD ➔ MP ➔ OB   67 (3.0)
    3                                                   MP ➔ OB                                                                245 (4.4)                                                                AD ➔ MP   253 (9.7)     MP ➔ AD ➔ OB    37 (0.7)    MP ➔ AD ➔ OB   61 (2.3)
                                                                                                                                                                                                                                                                           
  **35--44 years; female: 6747, male: 3583**                                                                                                                                                                                                                               
    1                                                   AD ➔ OB                                                                327 (4.8)                                                                MP ➔ OB   497 (14..0)   AD ➔ MP ➔ OB    57 (0.8)    AD ➔ OB ➔ MP   203 (5.7)
    2                                                   MP ➔ OB                                                                318 (4.7)                                                                AD ➔ OB   333 (9.2)     AD ➔ OB ➔ MP    51 (0.8)    MP ➔ OB ➔ AD   115 (3.2)
    3                                                   AD ➔ MP                                                                256 (3.8)                                                                MP ➔ AD   330 (9.2)     MP ➔ OB ➔ AD    48 (0.7)    MP ➔ AD ➔ OB   76 (2.1)
                                                                                                                                                                                                                                                                           
  **45--64 years; female: 18 426, male: 12 372**                                                                                                                                                                                                                           
    1                                                   MP ➔ OB                                                                456 (2.5)                                                                MP ➔ OB   674 (5.4)     HT ➔ OB ➔ MP    87 (0.5)    HT ➔ OB ➔ HL   291 (2.4)
    2                                                   AD ➔ OB                                                                400 (2.2)                                                                HT ➔ OB   472 (3.8)     AD ➔ OB ➔ MP    80 (0.4)    MP ➔ OB ➔ HL   205 (1.7)
    3                                                   AD ➔ MP                                                                365 (2.0)                                                                AD ➔ OB   404 (3.3)     MP ➔ OB ➔ AD    78 (0.4)    MP ➔ OB ➔ HT   162 (1.3)
                                                                                                                                                                                                                                                                           
  **65--84 years: female: 12 819, male: 9652**                                                                                                                                                                                                                             
    1                                                   HT ➔ OB                                                                322 (2.5)                                                                HT ➔ OB   323 (3.3)     HT ➔ OB ➔ HL    48 (0.4)    DB ➔ OB ➔ HT   129 (1.3)
    2                                                   HT ➔ MP                                                                102 (0.8)                                                                DB ➔ OB   158 (1.7)     HT ➔ OB ➔ MP    46 (0.4)    HT ➔ OB ➔ MP   100 (1.0)
    3                                                   HT ➔ HL                                                                98 (0.8)                                                                 HT ➔ HL   147 (1.6)     DB ➔ OB ➔ HT    42 (0.3)    HT ➔ OB ➔ HL   97 (1.0)
                                                                                                                                                                                                                                                                           
  ≥**85 years: female: 3824, male: 2247**                                                                                                                                                                                                                                  
    1                                                   HT ➔ OB                                                                62 (1.6)                                                                 HT ➔ OB   76 (3.4)      HT ➔ OB ➔ ORA   15 (0.4)    DB ➔ OB ➔ HT   31 (1.4)
    2                                                   HT ➔ DE                                                                53 (1.4)                                                                 HT ➔ CA   69 (3.1)      HT ➔ OB ➔ CA    14 (0.4)    HT ➔ OB ➔ MP   26 (1.2)
    3                                                   HT ➔ CD                                                                44 (1.2)                                                                 HT ➔ CD   63 (2.9)      HT ➔ OB ➔ MP    12 (0.3)    HT ➔ OB ➔ CA   21 (1.0)

Excluding data points where the time elapsing between chronic condition diagnoses was zero days.

Rank indicates that the permutations are listed in order of frequency (starting with most frequent).

Permutations presented in temporal order.

Proportion of age group and results representing \<5 patients within age group supressed. AD = Anxiety or Depression. CA = Cancer. CD = Cardiovascular Disease. DB = Diabetes. DE = Dementia. HL = Hyperlipidemia. HT = Hypertension. MP = Musculoskeletal Problem. OB = Obesity. ORA = Osteoarthritis or Rheumatoid Arthritis. The arrows between conditions are used to identify permutations (ordered patterns).

As seen in [Table 2](#table2){ref-type="table"}, the most prevalent combination among the youngest age groups was anxiety or depression and obesity, identified among those aged 18--34 years (10.4% and 12.0% among female and male patients, respectively) and 35--44 years (7.7%) among female patients. The most prevalent combination among male patients aged 35--44 years was musculoskeletal problem and obesity (10.2%).

As seen in [Table 3](#table3){ref-type="table"}, there was a clear distinction between patients aged 18--64 years whose most prevalent first diagnosis was anxiety or depression, as compared with patients aged ≥65 years whose most prevalent first diagnosis was hypertension. (Among patients aged 45--64 years, musculoskeletal problem was detected as a prevalent first diagnosis, potentially due to the diagnosis of ongoing back pain \[and other chronic pain\] among patients \[both females and males\] in this age group.) The type of combinations and permutations that were detected became increasingly rare as two characteristics increased: patient age and the total number of chronic conditions.

As a result of these small clusters, results were suppressed where less than five patients were included in an ordered sequence. Data for patients with at least four chronic conditions are available from the authors on request.

Prevalence of individual chronic conditions and frequency of occurrence in patterns
-----------------------------------------------------------------------------------

The prevalence estimates of the individual chronic condition categories among all adult patients, as well as patients with multimorbidity, are available from the authors on request. The most prevalent chronic condition diagnoses were obesity, hypertension, musculoskeletal problem, and anxiety or depression. The least prevalent chronic condition diagnoses among both groups were stroke or transient ischaemic attack, liver disease, and kidney disease or failure.

Each of these chronic conditions had a prevalence of \<1% for female and male patients. The frequency with which individual chronic conditions appeared in combinations, permutations, and as the first chronic condition within permutations are available from the authors on request. Hypertension, obesity, and musculoskeletal problem were present in approximately 50% of combinations and 50% of permutations for females and males.

Hypertension was the only chronic condition that presented as the first chronic condition in \>20% of permutations among patients.

DISCUSSION
==========

Summary
-------

To the authors' knowledge, this is the first study to investigate the combinations and permutations of multimorbidity in a national EMR database using a longitudinal and computational approach. This study found that among the sample of adult primary care patients, approximately one in two and one in three patients were living with MM2+ and MM3+, respectively. For both definitions, the largest proportion of patients with multimorbidity was aged \<65 years. The current study also found that the patterns of multimorbidity represented increasingly unique combinations and permutations, demonstrating that multimorbidity should be explored at a more in-depth level than identifying pairs or triplets of chronic conditions. Some of the patterns that were detected were logical clinically (for example, co-occurrences of obesity, musculoskeletal problem, and anxiety or depression), but there were thousands of combinations and permutations that included fewer than five patients. There were 4981 combinations and 13 858 permutations with fewer than five female patients and 3565 combinations and 8999 permutations with fewer than five male patients.

Strengths and limitations
-------------------------

A strength of this study was the longitudinal EMR data that allowed for the study of multimorbidity over time and the identification of frequent and rare clinical profiles. In addition, the computational analysis used can be applied to longitudinal datasets in other settings. Limitations include the fact that the CPCSSN database does not capture variables that can be particularly important in the progression of multimorbidity, such as condition severity or self-management; the measure of multimorbidity did not distinguish between transient or controlled chronic conditions; and the estimate of multimorbidity was determined among those patients who were already seeking care from their primary care provider, which may have produced artificially high rates.

Finally, the use of EMR data may have introduced the potential for misclassification of chronic condition occurrence because diagnostic information may not have been recorded or extracted properly from the EMR systems and into the EMR database. This is an important consideration when using EMR data for epidemiological research because these data are collected for clinical, not research, purposes.[@b45]^--^[@b47]

Comparison with existing literature
-----------------------------------

The prevalence estimates of multimorbidity in this study are comparable with many international estimates to date. More specifically, the findings were most comparable with prevalence estimates from the UK at 58.0%,[@b26] the US at 45.2%,[@b48] and Australia at 47.4%.[@b49] The findings that adult primary care patients with multimorbidity tended to be older and female has been corroborated in the existing literature.[@b50]^--^[@b55] While the prevalence of multimorbidity increased as patient age increased, the largest proportion of patients in the current study was aged \<65 years. This is consistent with previous literature highlighting the growing burden of multimorbidity among younger cohorts. For example, a study conducted by Ryan *et al* [@b56] examined rates of multimorbidity in the province of Ontario and concluded that the 'common rhetoric' around the 'grey tsunami' is incorrect because the volume of multimorbidity is beginning in younger individuals. It is clear that multimorbidity is no longer an issue of older patients and it must be appropriately managed among younger patients.[@b26]^,^[@b51]^,^[@b56]^,^[@b57]

A study conducted by van den Bussche *et al* [@b58] examined multimorbidity clusters in primary care data in Germany, which found similar trends for the most prevalent individual chronic conditions (such as hypertension, chronic low back pain, diabetes, and joint arthrosis) and a very large number of unique combinations of multimorbidity. In these data, 10 426 combinations (from a list of 45 chronic conditions) were detected.[@b58] This work is comparable with the current study, which used less than half the number of chronic conditions and found about half the number of combinations in the primary care data.

Implications for research
-------------------------

These in-depth analyses contribute to the global research on multimorbidity,[@b1]^,^[@b59] and identify distinct 'types' of multimorbidity in specific age groups of patients, and support the need for care delivery that accounts for the evolution of multimorbidity over time.[@b60]^--^ [@b63] While beyond the scope of the current research, the findings reported in this article could be used to re-examine the potential for effective case management through a more tailored approach to multimorbidity and a more integrated set of health services. Indeed, this research provides empirical evidence of the nuanced complexity of patients living with multimorbidity and the corresponding need for individualised and patient-centred delivery of clinical care.
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